KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInvested CapitalNet Margin

National Health Investors (NHI) Enterprise Value (2016 - 2026)

National Health Investors filings provide 18 years of Enterprise Value readings, the most recent being -$17.1 million for Q1 2026.

  • On a quarterly basis, Enterprise Value rose 86.47% to -$17.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$17.1 million, a 86.47% increase, with the full-year FY2025 number at -$9.4 million, up 34.97% from a year prior.
  • Enterprise Value hit -$17.1 million in Q1 2026 for National Health Investors, down from -$9.4 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$1.9 million in Q1 2024 to a low of -$126.4 million in Q1 2025.
  • Median Enterprise Value over the past 5 years was -$9.5 million (2022), compared with a mean of -$23.0 million.
  • Biggest five-year swings in Enterprise Value: surged 87.94% in 2023 and later crashed 6444.15% in 2025.
  • National Health Investors' Enterprise Value stood at -$9.5 million in 2022, then crashed by 34.07% to -$12.7 million in 2023, then fell by 14.25% to -$14.5 million in 2024, then surged by 34.97% to -$9.4 million in 2025, then tumbled by 81.47% to -$17.1 million in 2026.
  • The last three reported values for Enterprise Value were -$17.1 million (Q1 2026), -$9.4 million (Q4 2025), and -$73.1 million (Q3 2025) per Business Quant data.